(Q36623128)

15 August 2017

1 reference

title

Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers (English)

1 reference

15 August 2017

1 reference

Masahiro Maeda

1

1 reference

15 August 2017

Okio Hino

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

15 August 2017

published in

Pathology International

1 reference

15 August 2017

volume

56

1 reference

15 August 2017

issue

11

1 reference

15 August 2017

page(s)

649-654

1 reference

Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Soluble mesothelin-related protein--a blood test for mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Different ARF domains are required for the activation of cholera toxin and phospholipase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Mapping and determination of the cDNA sequence of the Erc gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Mesothelin: a new target for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Mesothelin variant 1 is released from tumor cells as a diagnostic marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Cellular and molecular parameters of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Validation of genomics-based prognostic tests in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

Soluble Mesothelin–related Peptides in the Diagnosis of Malignant Pleural Mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2006.02024.X

10.1111/J.1440-1827.2006.02024.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference